581 related articles for article (PubMed ID: 314300)
1. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
2. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
4. Correlation of surface receptors with histological appearance in 29 cases of non-Hodgkin lymphoma.
Habeshaw JA; Macaulay RA; Stuart AE
Br J Cancer; 1977 Jun; 35(6):858-67. PubMed ID: 301396
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
6. Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?
Rose ML; Habeshaw JA; Kennedy R; Sloane J; Wiltshaw E; Davies AJ
Br J Cancer; 1981 Jul; 44(1):68-74. PubMed ID: 6789856
[TBL] [Abstract][Full Text] [Related]
7. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
8. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
10. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
[TBL] [Abstract][Full Text] [Related]
12. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
Derre M; Tubiana N; Carcassonne Y
Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
[TBL] [Abstract][Full Text] [Related]
13. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
14. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
Herrmann F; Wirthmüller R
Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
[TBL] [Abstract][Full Text] [Related]
15. Malignant lymphoma of the testis.
Baldetorp LA; Brunkvall J; Cavallin-Ståhl E; Henrikson H; Holm E; Olsson AM; Akerman M
Br J Urol; 1984 Oct; 56(5):525-30. PubMed ID: 6398719
[TBL] [Abstract][Full Text] [Related]
16. Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry.
Landaas TO; Godal T; Marton PF; Kvaløy S; Langholm R; Lindmo T; Jørgensen OG; Høst H
Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):91-101. PubMed ID: 7023187
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
19. Identification of two major B cell forms of nodular mixed lymphoma.
Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
[TBL] [Abstract][Full Text] [Related]
20. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
